Portfolio Design Labs LLC Sells 1,554 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Portfolio Design Labs LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,372 shares of the healthcare conglomerate's stock after selling 1,554 shares during the quarter. UnitedHealth Group comprises about 1.2% of Portfolio Design Labs LLC's portfolio, making the stock its 16th biggest position. Portfolio Design Labs LLC's holdings in UnitedHealth Group were worth $4,310,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV grew its holdings in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate's stock valued at $7,288,000 after acquiring an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate's stock valued at $14,603,000 after acquiring an additional 3,006 shares in the last quarter. Americana Partners LLC grew its holdings in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate's stock valued at $11,914,000 after acquiring an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate's stock valued at $5,072,000 after acquiring an additional 1,283 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH traded up $23.50 during mid-day trading on Wednesday, reaching $600.50. 3,921,374 shares of the company traded hands, compared to its average volume of 3,880,279. The stock has a market capitalization of $552.63 billion, a P/E ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's fifty day moving average price is $582.31 and its 200-day moving average price is $551.25. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the business posted $6.56 EPS. UnitedHealth Group's revenue was up 9.2% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several research reports. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. StockNews.com lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Wednesday. Barclays reduced their price objective on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Finally, Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.